Insights into Rare Disease Drug Approval:Trends and Recent Developments Mike Lanthier Operations Research Analyst FDA Office of the Commissioner NORD Rare Diseases & Orphan Products Breakthrough Summit, October 17, 2017
Posts Tagged ‘Insights into Rare Disease Drug Approval’